Everolimus does not prevent Lafora body formation in murine Lafora disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received October 24, 2016
- Accepted in final form December 7, 2016
- First Published January 9, 2017.
Author Disclosures
- Navin Mishra, MD,
- Peixiang Wang, PhD,
- Danielle Goldsmith, BSc,
- Xiaochu Zhao, BSc,
- Yunlin Xue, BSc,
- Uwe Christians, MD, PhD and
- Berge A. Minassian, MD
- Navin Mishra, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Peixiang Wang, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Danielle Goldsmith, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Xiaochu Zhao, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yunlin Xue, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Uwe Christians, MD, PhD and
NONE
NONE
NONE
Therapeutic Drug Monitoring, Editor-in-Chief, 1 year
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Novartis, expert witness, 2015-2016
- Berge A. Minassian, MD
NONE
NONE
NONE
NONE
Patents for diagnostic testing of the following genes: EPM2A, EPM2B, MECP2, VMA21
NONE
NONE
NONE
NONE
NONE
NONE
NONE
National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) under award number P01 NS097197
NONE
NONE
NONE
From patents for diagnostic testing of the following genes: EPM2A, EPM2B, MECP2, VMA21
From patents for diagnostic testing of the following genes: EPM2A, EPM2B, MECP2, VMA21
NONE
NONE
NONE
- From the Department of Paediatrics (Neurology) (N.M., B.A.M.) and Program in Genetics and Genome Biology (P.W., D.G., X.Z., Y.X., B.A.M.), The Hospital for Sick Children and University of Toronto, Canada; and iC42 Clinical Research and Development (U.C.), Department of Anesthesiology, University of Colorado, Denver.
- Correspondence to Dr. Minassian: berge.minassian{at}sickkids.ca
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Clinical Implications of Neuroscience Research
Glycogen metabolismMetabolic coupling between astrocytes and neuronsEduardo E. Benarroch et al.Neurology, March 15, 2010 -
Editorials
Lafora progressive myoclonus epilepsyGlycogen storage disease vs neurodegenerative diseaseAntonio V. Delgado-Escueta et al.Neurology, May 23, 2012 -
Clinical/Scientific Notes
Ketogenic diet reduces Lafora bodies in murine Lafora diseaseLori Israelian, Peixiang Wang, Shoghig Gabrielian et al.Neurology: Genetics, November 19, 2020 -
Clinical/Scientific Notes
Lafora bodies in skeletal muscle are fiber type specificJ. Turnbull, J.-M. Girard, N. Pencea et al.Neurology, March 30, 2011